• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: Japan

Nomura NEXT FUNDS TOPIX-17 Pharmaceutical ETF

+ Add to Watchlist

1621:JP

14,600.0000 JPY 120.0000 0.82%

As of 01:57:09 ET on 07/24/2014.

Snapshot for Nomura NEXT FUNDS TOPIX-17 Pharmaceutical ETF (1621)

Open: 14,720.0000 High - Low: 14,720.0000 - 14,600.0000 Primary Exchange: Tokyo
Volume: 210 52-Week Range: 13,070.0000 - 15,730.0000 Beta vs TP17PHRM: 0.9522

ETF Chart for 1621

No chart data available.
  • 1621:JP 14,600.0000
  • 1D
  • 1M
  • 1Y
14,720.0000
Interactive 1621 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for 1621

NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF is an exchange-traded fund incorporated in Japan. The objective of the Fund is to provide investment results that correspond to the performance of the TOPIX-17 Pharmaceutical Index.

Inception Date: 2008-03-25 Telephone: 81-3-3241-9511
Managers: -
Web Site: www.nomura-am.co.jp

Fundamentals for 1621

NAV (on 2014-07-23) 14,634.8000
Assets (M) (on 2014-07-23) 900.0000
Shares out (M) 0.06
Market Cap (M) 897.86
% Premium 0.58
Average 52-Week % Premium -0.1579
Fund Leveraged N

Dividends for 1621

Dividend Type Distribution
Dividend Frequency Annual
Last Dividend Net (on 2014-07-11) 1,067.0000
Dividend Yield (ttm) 7.31%

Performance for 1621

1-Month +2.48% 1-Year +8.69%
3-Month +11.69% 3-Year +18.05%
Year To Date +5.14% 5-Year +10.94%
Expense Ratio 0.32

Top Fund Holdings for 1621

Filing Date: 06/30/2014
Name Position Value % of Total
Takeda Pharmaceutical Co Ltd 30,900 145,199,100 22.583%
Astellas Pharma Inc 94,100 125,247,100 19.480%
Otsuka Holdings Co Ltd 16,400 51,496,000 8.009%
Daiichi Sankyo Co Ltd 26,000 49,140,000 7.643%
Eisai Co Ltd 10,200 43,288,800 6.733%
Ono Pharmaceutical Co Ltd 3,800 33,896,000 5.272%
Shionogi & Co Ltd 12,900 27,270,600 4.241%
Chugai Pharmaceutical Co Ltd 8,200 23,411,000 3.641%
Santen Pharmaceutical Co Ltd 3,000 17,100,000 2.660%
Taisho Pharmaceutical Holdings 2,000 14,780,000 2.299%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil